Malatya Training and Research Hospital
Malatya, 44000, Turkey (Türkiye)
NCT Number: NCT07736924
This prospective observational case-control study will investigate whether the 2D:4D digit ratio is associated with urinary stone disease. Adults undergoing non-contrast computed tomography at Malatya Training and Research Hospital will be classified as cases if kidney and/or ureteral stones are detected and as controls if no urinary stones are detected and there is no previous history of stone disease or stone surgery. The lengths of the second and fourth fingers of both hands will be measured using a digital caliper by two independent observers who are blinded to the participant group. The study will also examine whether the 2D:4D ratio is associated with recurrent stone disease, stone burden, and bilateral or multiple stones.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Malatya, 44000, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At enrollment, during the single study assessment
The lengths of the second and fourth digits of both hands will be measured using a digital caliper by two independent observers blinded to group status. Right and left 2D:4D ratios will be calculated by dividing the length of the second digit by the length of the fourth digit. The mean bilateral 2D:4D ratio will be calculated as the average of the right and left ratios and compared between participants with computed tomography-confirmed kidney and/or ureteral stones and stone-free controls.
Time frame: At enrollment, during the single study assessment
Among participants with computed tomography-confirmed kidney and/or ureteral stones, recurrent stone disease will be defined as at least one previous physician-diagnosed urinary stone episode, spontaneous stone passage, or stone-related surgical intervention before the current stone episode. The mean bilateral 2D:4D ratio will be compared between participants with recurrent stone disease and those experiencing their first documented stone episode.
Time frame: At enrollment, during the single study assessment
Among participants with computed tomography-confirmed kidney and/or ureteral stones, total stone burden will be calculated as the sum of the maximum diameters of all detected stones in millimeters on non-contrast computed tomography. The association between mean bilateral 2D:4D ratio and total stone burden will be evaluated.
Time frame: At enrollment, during the single study assessment
Among participants with computed tomography-confirmed kidney and/or ureteral stones, bilateral stone disease will be defined as the presence of stones on both sides of the urinary tract, and multiple stone disease will be defined as the presence of two or more distinct stones. The mean bilateral 2D:4D ratio will be compared between participants with bilateral and/or multiple stones and those with a solitary unilateral stone.
Contact information is provided by the study sponsor or research team.
Emrah Kızılay
Other
Association Between 2D:4D Digit Ratio and Urinary Stone Disease: A Prospective Observational Case-Control Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06412900
Calculi, Female Urogenital Diseases
Oslo, Norway
View Trial DetailsNCT04594161
Acute Kidney Injury, Bites and Stings
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT04112160
Calculi, Female Urogenital Diseases
Dallas, Texas, United States
View Trial DetailsNCT06083051
Calculi, Female Urogenital Diseases
Madison, Wisconsin, United States
View Trial Details